{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:08:50Z","timestamp":1790770130000,"version":"4.1.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Disruption in the delicate symphony of genes, microRNA (miRNA), or protein expression can result in the dysregulation of the immune system, leading to the devastating consequences such as lupus nephritis (LN). The capacity of exosomes to transport miRNAs between cells and modify the phenotype of recipient cells implies their involvement in persistent kidney inflammation. This study unveils identifying two previously undiscovered exosomal miRNAs in the serum of LN patients, offering potential solutions to the current challenges in LN diagnosis and management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Initially, we used a reagent-based kit to isolate serum exosomes from patients with Systemic lupus erythematosus (SLE) and used Trizol method for total RNA extraction. Subsequently, we employed small RNA sequencing to screen for differential expression profiles of exosomal small RNAs. The RT-qPCR method was used to individually validate samples in both the screening and validation cohorts, enabling the identification of candidate small RNAs; specific to LN. We assessed the diagnostic potency using receiver operating characteristic (ROC) curve, and explored the biological roles of miRNAs using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared to SLE patients without LN, SLE patients accompanied by LN exhibited significantly spiked levels of exosomal hsa-miR-4796-5p and hsa-miR-7974. The duo of miRNAs, hsa-miR-4796-5p and hsa-miR-7974, exhibited promising potential as biomarkers for diagnosing LN, with an AUC exceeding 0.8. Correlation analysis revealed a strong positive association between these miRNAs and proteinuria, as well as the SLE Disease Activity Index (SLEDAI) score. Moreover, the levels of two miRNAs in LN patients were significantly elevated in comparison to other autoimmune nephritis conditions, such as immunoglobulin A nephropathy (IgAN) and diabetic nephropathy (DN). Furthermore, the bioinformatics analysis indicated that this miRNAs duo can play a pivotal role in the regulation of immune processes by modulating signal pathways, such as the mTOR and PI3K-Akt signaling pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study provides a new ground that serum exosomal miRNAs can effectively identify and predict LN in SLE patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2023.1326836","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T05:16:56Z","timestamp":1703827016000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Circulating exosomal microRNAs as biomarkers of lupus nephritis"],"prefix":"10.3389","volume":"14","author":[{"given":"Fei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,12,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/annrheumdis-2020-218272","article-title":"Update omicronn the diagnosis and management of systemic lupus erythematosus","volume":"80","author":"Fanouriakis","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/ard-2022-223741","article-title":"Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets","volume":"82","author":"Crow","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-216924","article-title":"2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of lupus nephritis","volume":"79","author":"Fanouriakis","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102871","article-title":"Lupus nephritis: new progress in diagnosis and treatment","volume":"132","author":"Yu","year":"2022","journal-title":"J Autoimmun"},{"key":"B8","doi-asserted-by":"publisher","first-page":"7143","DOI":"10.3390\/ijms22137143","article-title":"Immune-related urine biomarkers for the diagnosis of lupus nephritis","volume":"22","author":"Morell","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.09.012","article-title":"The lupus nephritis management renaissance","volume":"101","author":"Mejia-Vilet","year":"2022","journal-title":"Kidney Int"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat Rev Genet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biochem-060308-103103","article-title":"Regulation of mRNA translation and stability by microRNAs","volume":"79","author":"Fabian","year":"2010","journal-title":"Annu Rev Biochem"},{"key":"B12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/cdd.2014.112","article-title":"The complexity of miRNA-mediated repression","volume":"22","author":"Wilczynska","year":"2015","journal-title":"Cell Death Differ"},{"key":"B13","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases","volume":"18","author":"Chen","year":"2008","journal-title":"Cell Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.164947","article-title":"MYC regulates CSF1 expression via microRNA 17\/20a to modulate tumor-associated macrophages in osteosarcoma","volume":"8","author":"Nirala","year":"2023","journal-title":"JCI Insight"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-021-00354-w","article-title":"MicroRNA-mediated regulation of glucose and lipid metabolism","volume":"22","author":"Agbu","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102438","article-title":"Clinical significance of miRNAs in autoimmunity","volume":"109","author":"Zhang","year":"2020","journal-title":"J Autoimmun"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13055","article-title":"MicroRNA expression in extracellular vesicles as a novel blood-based biomarker for Alzheimer's disease","volume":"19","author":"Kumar","year":"2023","journal-title":"Alzheimers Dement"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3978","article-title":"Extracellular vesicles: biology and emerging therapeutic opportunities","volume":"12","author":"ELA","year":"2013","journal-title":"Nat Rev Drug Discovery"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102540","article-title":"Extracellular vesicles and lupus nephritis - New insights into pathophysiology and clinical implications","volume":"115","author":"Zhao","year":"2020","journal-title":"J Autoimmun"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/bs.acc.2016.06.005","article-title":"Microvesicles in autoimmune diseases","volume":"77","author":"Liu","year":"2016","journal-title":"Adv Clin Chem"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315580146","article-title":"Galectin-3 binding protein links circulating microparticles with electron dense glomerular deposits in lupus nephritis","volume":"24","author":"Nielsen","year":"2015","journal-title":"Lupus"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(83)90040-5","article-title":"Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor","volume":"33","author":"Pan","year":"1983","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.98204","article-title":"Exosome-delivered microRNAs promote IFN-alpha secretion by human plasmacytoid DCs via TLR7","volume":"3","author":"Salvi","year":"2018","journal-title":"JCI Insight"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105680","article-title":"The emerging roles of exosomes in autoimmune diseases, with special emphasis on microRNAs in exosomes","volume":"169","author":"Miao","year":"2021","journal-title":"Pharmacol Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"7088","DOI":"10.3390\/ijms24087088","article-title":"Plasma exosomal non-coding RNA profile associated with renal damage reveals potential therapeutic targets in lupus nephritis","volume":"24","author":"Flores-Chova","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheum"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2012.03569.x","article-title":"Nanoparticle tracking analysis monitors microvesicle and exosome secretion from immune cells","volume":"136","author":"Soo","year":"2012","journal-title":"Immunology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2023.124416","article-title":"Sequential isolation of metabolites and lipids from a single sample to achieve multiomics by using TRIzol reagent","volume":"258","author":"Kao","year":"2023","journal-title":"Talanta"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30546-X","article-title":"Novel paradigms in systemic lupus erythematosus","volume":"393","author":"Dorner","year":"2019","journal-title":"Lancet"},{"key":"B33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12943-022-01505-z","article-title":"Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring","volume":"21","author":"Li","year":"2022","journal-title":"Mol Cancer"},{"key":"B34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","article-title":"Metazoan microRNAs","volume":"173","author":"Bartel","year":"2018","journal-title":"Cell"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4126106","article-title":"The involvement of microRNAs in modulation of innate and adaptive immunity in systemic lupus erythematosus and lupus nephritis","volume":"2018","author":"Honarpisheh","year":"2018","journal-title":"J Immunol Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2018.10.004","article-title":"Serum miRNA-371b-5p and miRNA-5100 act as biomarkers for systemic lupus erythematosus","volume":"196","author":"Zeng","year":"2018","journal-title":"Clin Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00393-023-01319-4","article-title":"MicroRNA-125b mediates Interferon-gamma-induced downregulation of the vitamin D receptor in systemic lupus erythematosus","volume":"2","author":"Gu","year":"2023","journal-title":"Z Rheumatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-5","article-title":"Identification and proteomic profiling of exosomes in human cerebrospinal fluid","volume":"10","author":"Street","year":"2012","journal-title":"J Transl Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.3.1969","article-title":"Exosomes with immune modulatory features are present in human breast milk","volume":"179","author":"Admyre","year":"2007","journal-title":"J Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1053\/j.gastro.2023.06.021","article-title":"Salivary extracellular microRNAs for early detection and prognostication of esophageal cancer: A clinical study","volume":"165","author":"Li","year":"2023","journal-title":"Gastroenterology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s10020-023-00727-1","article-title":"Aerobic exercise improves cognitive impairment in mice with type 2 diabetes by regulating the MALAT1\/miR-382-3p\/BDNF signaling pathway in serum-exosomes","volume":"29","author":"Wang","year":"2023","journal-title":"Mol Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12933-023-01887-4","article-title":"Differential expression of coagulation pathway-related proteins in diabetic urine exosomes","volume":"22","author":"Liu","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2019.07.011","article-title":"Extracellular miRNAs: from biomarkers to mediators of physiology and disease","volume":"30","author":"Mori","year":"2019","journal-title":"Cell Metab"},{"key":"B44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.gpb.2015.02.001","article-title":"Exosome and exosomal microRNA: trafficking, sorting, and function","volume":"13","author":"Zhang","year":"2015","journal-title":"Genomics Proteomics Bioinf"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1077645","article-title":"Urinary exosome tsRNAs as novel markers for diagnosis and prediction of lupus nephritis","volume":"14","author":"Chen","year":"2023","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041561","article-title":"Comparing the MicroRNA spectrum between serum and plasma","volume":"7","author":"Wang","year":"2012","journal-title":"PloS One"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v3.23743","article-title":"Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood","volume":"3","author":"Cheng","year":"2014","journal-title":"J Extracell Vesicles"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1136\/annrheumdis-2019-215505","article-title":"Blood plasma versus serum: which is right for sampling circulating membrane microvesicles in human subjects","volume":"79","author":"Liu","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e12302","DOI":"10.1002\/jev2.12302","article-title":"Platelet removal from human blood plasma improves detection of extracellular vesicle-associated miRNA","volume":"12","author":"Bracht","year":"2023","journal-title":"J Extracell Vesicles"},{"key":"B50","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1373\/clinchem.2013.206375","article-title":"The digital MIQE guidelines: Minimum Information for Publication of Quantitative Digital PCR Experiments","volume":"59","author":"Huggett","year":"2013","journal-title":"Clin Chem"},{"key":"B51","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ni.2005","article-title":"The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2","volume":"12","author":"Delgoffe","year":"2011","journal-title":"Nat Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/ndt\/gfq496","article-title":"The PI3K\/Akt\/mTOR pathway is activated in murine lupus nephritis and downregulated by rapamycin","volume":"26","author":"Stylianou","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.7367","article-title":"Association of BAFF with PI3K\/Akt\/mTOR signaling in lupus nephritis","volume":"16","author":"Ge","year":"2017","journal-title":"Mol Med Rep"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.7150\/thno.22958","article-title":"Exosomal DMBT1 from human urine-derived stem cells facilitates diabetic wound repair by promoting angiogenesis","volume":"8","author":"Chen","year":"2018","journal-title":"Theranostics"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1326836\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T05:16:59Z","timestamp":1703827019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1326836\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,29]]},"references-count":54,"alternative-id":["10.3389\/fimmu.2023.1326836"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1326836","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,29]]},"article-number":"1326836"}}